IOWA STUDY (Summary)
IOWA (Investigating Oils With respect to Arterial blockage) Experiment
This is the first experiment using photoplethysmography to detail the differences in arterial flexibility between subjects taking Pure Form Omega® and those taking fish oil. IOWA is the first experiment conclusively proving the superiority of the Essential Fatty Acids (EFAs) of Pure Form Omega® to fish oil as regards to cardiovascular protection.
The IOWA experiment was run under the direction of Prof. Brian Peskin in conjunction with renowned interventional cardiologist David Sim, M.D. (of Boise, Idaho). Long-term Pure Form Omega® supplementation in patients presenting with a broad spectrum of maladies resulted in: 35 subjects, 13 male and 22 female, aged 35-75. The median age was 62 years old. These volunteers were supplemented with plant-based EFAs for a period of 3 months to 48 months. The median duration of use was 24 months. Half of the subjects used the EFA formulation for less than 24 months and half used it for more than 24 months.
Twenty-five of the subjects improved their arterial flexibility. That’s a 73% effectiveness rate (absolute — not relative). The average improvement was a 9-year decrease in biological arterial age, making their effective age younger than their physical age.
What is remarkable was the NNT (number needed to treat to see an effect in just one person) was 1.4. Pharma companies consider an NNT of less than 50 a good result for the effectiveness of their drugs. For example, for statins, the NNT to “prevent” one cardiovascular event is >80. That means more than 80 people would need to take a statin to see a single positive outcome. In contrast, just 1.4 people taking parent essential oils are required to see a positive outcome in 1 person. The statistical significance of the experiment, according to Alex Kiss, PhD, a statistician who has worked as consultant to the National Institute of Health (NIH) and is co-author of numerous peer reviewed medical journal papers, including New England Journal of Medicine and Cancer, is extremely high (99.85%), compared to most studies, which come in at only 95%. This experiment is 30 times more accurate than the average clinical study. That means the results can’t be due to chance or error. The mean (average) arterial (biological) age of the subjects dropped over 8.8 years — making each of them in effect a younger patient!